A detailed history of Fil LTD transactions in Becton Dickinson & CO stock. As of the latest transaction made, Fil LTD holds 11,104 shares of BDX stock, worth $2.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,104
Previous 12,550 11.52%
Holding current value
$2.53 Million
Previous $2.93 Million 8.73%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$221.47 - $242.41 $320,245 - $350,524
-1,446 Reduced 11.52%
11,104 $2.68 Million
Q2 2024

Aug 13, 2024

BUY
$225.07 - $246.17 $2.01 Million - $2.2 Million
8,918 Added 245.54%
12,550 $2.93 Million
Q1 2024

May 13, 2024

SELL
$233.45 - $247.73 $532,732 - $565,319
-2,282 Reduced 38.59%
3,632 $898,000
Q4 2023

Feb 13, 2024

SELL
$232.24 - $267.23 $63 Million - $72.5 Million
-271,395 Reduced 97.87%
5,914 $1.44 Million
Q3 2023

Nov 13, 2023

SELL
$254.9 - $283.59 $24 Million - $26.7 Million
-94,163 Reduced 25.35%
277,309 $71.7 Million
Q2 2023

Aug 11, 2023

BUY
$238.39 - $265.32 $74.7 Million - $83.1 Million
313,363 Added 539.27%
371,472 $98.1 Million
Q1 2023

May 11, 2023

SELL
$229.71 - $259.35 $74.8 Million - $84.5 Million
-325,705 Reduced 84.86%
58,109 $14.4 Million
Q4 2022

Feb 13, 2023

BUY
$218.29 - $256.91 $12.8 Million - $15.1 Million
58,699 Added 18.05%
383,814 $97.6 Million
Q3 2022

Nov 10, 2022

SELL
$51.03 - $264.23 $9.48 Million - $49.1 Million
-185,832 Reduced 36.37%
325,115 $72.4 Million
Q2 2022

Aug 12, 2022

BUY
$234.74 - $275.42 $5.52 Million - $6.48 Million
23,510 Added 4.82%
510,947 $126 Million
Q1 2022

May 13, 2022

BUY
$243.64 - $270.48 $6 Million - $6.67 Million
24,642 Added 5.32%
487,437 $130 Million
Q4 2021

Feb 14, 2022

BUY
$230.08 - $250.94 $28.2 Million - $30.7 Million
122,375 Added 35.95%
462,795 $116 Million
Q3 2021

Nov 15, 2021

BUY
$232.72 - $256.47 $50.4 Million - $55.5 Million
216,440 Added 174.58%
340,420 $83.7 Million
Q2 2021

Aug 13, 2021

BUY
$232.65 - $254.58 $12.8 Million - $14 Million
54,967 Added 79.65%
123,980 $30.2 Million
Q1 2021

May 14, 2021

SELL
$232.09 - $256.88 $19.4 Million - $21.5 Million
-83,730 Reduced 54.82%
69,013 $16.8 Million
Q4 2020

Feb 08, 2021

SELL
$221.92 - $245.94 $20.3 Million - $22.5 Million
-91,492 Reduced 37.46%
152,743 $38.2 Million
Q3 2020

Nov 13, 2020

BUY
$215.77 - $276.76 $20.7 Million - $26.6 Million
96,006 Added 64.77%
244,235 $56.8 Million
Q2 2020

Aug 13, 2020

SELL
$219.9 - $263.41 $9.93 Million - $11.9 Million
-45,143 Reduced 23.35%
148,229 $35.5 Million
Q1 2020

May 14, 2020

SELL
$195.69 - $279.01 $30.3 Million - $43.2 Million
-154,786 Reduced 44.46%
193,372 $44.4 Million
Q4 2019

Feb 07, 2020

SELL
$236.45 - $266.82 $4.65 Million - $5.24 Million
-19,655 Reduced 5.34%
348,158 $94.7 Million
Q3 2019

Nov 13, 2019

BUY
$230.58 - $256.08 $222,048 - $246,605
963 Added 0.26%
367,813 $93 Million
Q2 2019

Aug 13, 2019

BUY
$217.4 - $246.08 $26 Million - $29.4 Million
119,612 Added 48.38%
366,850 $92.5 Million
Q1 2019

May 13, 2019

BUY
$206.05 - $248.17 $13 Million - $15.6 Million
62,924 Added 34.14%
247,238 $61.7 Million
Q4 2018

Feb 13, 2019

BUY
$204.73 - $257.93 $16.2 Million - $20.4 Million
78,914 Added 74.87%
184,314 $41.5 Million
Q3 2018

Nov 09, 2018

BUY
$233.07 - $256.0 $4.48 Million - $4.93 Million
19,240 Added 22.33%
105,400 $27.5 Million
Q2 2018

Aug 10, 2018

BUY
$208.1 - $233.85 $2.71 Million - $3.04 Million
13,017 Added 17.8%
86,160 $20.6 Million
Q1 2018

May 14, 2018

BUY
$205.46 - $240.27 $49,721 - $58,145
242 Added 0.33%
73,143 $15.9 Million
Q4 2017

Feb 12, 2018

BUY
$189.0 - $222.64 $87,885 - $103,527
465 Added 0.64%
72,901 $15.6 Million
Q2 2017

Aug 29, 2017

BUY
N/A
72,436
72,436 $14.1 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.1B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Fil LTD Portfolio

Follow Fil LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.